Acetylsalicylic acid is also known as:

Choice A reason: Sedatives induce calm, not lower blood pressure directly. Vasodilators target BP reduction specifically. This choice errors per nursing pharmacology standards. It’s universally distinct as unrelated to BP management, lacking the required mechanism.

Choice B reason: Intermediate-acting defines duration, not BP-lowering action. Vasodilators reduce pressure effectively. This choice misaligns with nursing pharmacology definitions. It’s universally distinct, missing the functional role specified in the question.

Choice C reason: Vasodilators, like nitroglycerin, widen vessels, lowering BP efficiently. This matches nursing pharmacology standards precisely. It’s universally recognized, distinctly applied in practice for hypertension or angina management effectively.

Choice D reason: Vasoconstrictors raise BP, opposite of lowering it. Vasodilators fit the description accurately. This choice errors per nursing pharmacology principles. It’s universally distinct, contradicting the question’s intent entirely.

Choice A reason: Changes signal potential instability, not normal variation; returning is safer. This errors, per nursing pharmacology. It’s universally distinct, risking potency loss in administration.

Choice B reason: Altered color, consistency, or odor suggests degradation; returning ensures safety. This aligns with nursing standards. It’s universally applied, distinctly protecting patients from ineffective drugs.

Choice C reason: Nurses assess drugs, not just pharmacists; returning is nurse-initiated. This misplaces responsibility, per nursing pharmacology. It’s universally distinct, errors in duty allocation.

Choice D reason: Giving altered drugs risks harm; reporting alone isn’t enough. Returning is safer, per nursing standards. This fails universally, distinctly compromising medication safety.